Tower Research Capital (TRC)’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-200
Closed -$3.51K 5767
2024
Q2
$3.51K Hold
200
﹤0.01% 4883
2024
Q1
$3.47K Sell
200
-1,582
-89% -$26.5K ﹤0.01% 4859
2023
Q4
$28.7K Buy
1,782
+1,582
+791% +$24.1K ﹤0.01% 3449
2023
Q3
$2.96K Hold
200
﹤0.01% 5078
2023
Q2
$3.13K Buy
+200
New +$3.09K ﹤0.01% 5107
2022
Q4
Sell
-30
Closed 5985
2022
Q3
$0 Buy
+30
New +$434 ﹤0.01% 6145
2022
Q1
Sell
-4,849
Closed -$90K 6176
2021
Q4
$90K Buy
+4,849
New +$93.8K ﹤0.01% 2297

Other funds holding ECAT

Tower Research Capital (TRC)'s ECAT Position: Q3 2024 in Review

Tower Research Capital (TRC) sold out of BlackRock ESG Capital Allocation Term Trust (ECAT) in Q3 2024, closing a stake of 200 shares — an estimated $3.51K sold.

Tower Research Capital (TRC) first reported a position in ECAT in Q4 2021 and held it in 7 quarters. The position peaked at $90K in Q4 2021. 65 funds tracked by Wall St. Rank hold ECAT as of Q3 2024.

  • Tower Research Capital (TRC) reported no remaining BlackRock ESG Capital Allocation Term Trust position as of Q3 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 200 BlackRock ESG Capital Allocation Term Trust shares in Q3 2024, an estimated $3.51K.
  • Tower Research Capital (TRC) first reported a position in BlackRock ESG Capital Allocation Term Trust in Q4 2021 and held it in 7 quarters.
  • Tower Research Capital (TRC)'s BlackRock ESG Capital Allocation Term Trust position peaked at $90K in Q4 2021.
  • 65 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q3 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.